ASX slips 0.16pc as tech and materials sectors lag. Amplia Therapeutics reports a second complete response in its pancreatic cancer trial.

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Ausgold is on the home straight to deliver the key definitive feasibility study for its Katanning gold project in WA’s Great ...

Military metals tungsten, tin, beryllium, rare earths and antimony are on investors' radars as war rages in the Middle East.

These ASX mining juniors could be in the cross-hairs as 2025's next takeover targets according to our expert panel.

The ASX finished 0.15pc lower after a subdued day of trading. Investors are keeping to the sidelines as the Iran-Israel ...

Lithium Universe has executed a binding agreement to acquire the global rights to patented photovoltaic solar panel recycling ...

Potential Cyprus-style copper mineralisation at Earl’s Target highlights the untapped exploration potential of Firetail’s ...

We can demand that our children’s interests take precedence over foreign corporate interests, writes Chloe Shorten.

Iron ore slumps again but ASX recovers from early dip; Trump’s Iran blast rattles Wall Street; Uranium glows while NextDC ...

EUR and CRML have received a US$120M letter of interest to fund the development of the Tanbreez project in Greenland.

Mayne Pharma holders have voted overwhemingly in favour of Cosette's $600 million offer that's no longer on the table. See you in court.